(Q54247387)

26 May 2018

title

Use of evolutionary limitations of HIV-1 multidrug resistance to optimize therapy. (English)

1 reference

26 May 2018

main subject

multiple drug resistance

1 reference

Erratum: Use of evolutionary limitations of HIV-1 multidrug resistance to optimize therapy

inferred from title

corrigendum / erratum

0 references

5

Eron JJ

1 reference

26 May 2018

author name string

Chow YK

1

1 reference

26 May 2018

Hirsch MS

2

1 reference

26 May 2018

Merrill DP

3

1 reference

26 May 2018

Bechtel LJ

4

1 reference

26 May 2018

Kaplan JC

6

1 reference

26 May 2018

D'Aquila RT

7

1 reference

26 May 2018

language of work or name

English

0 references

publication date

1 February 1993

1 reference

26 May 2018

published in

Nature

1 reference

26 May 2018

volume

361

1 reference

26 May 2018

issue

6413

1 reference

26 May 2018

page(s)

650-654

1 reference

26 May 2018

https://scigraph.springernature.com/pub.10.1038/361650a0

exact match

0 references

cites work

Potent and selective inhibition of HIV-1 replication in vitro by a novel series of TIBO derivatives

1 reference

7 January 2021

Inhibition of HIV-1 Replication by a Nonnucleoside Reverse Transcriptase Inhibitor

1 reference

7 January 2021

Pyridinone derivatives: specific human immunodeficiency virus type 1 reverse transcriptase inhibitors with antiviral activity

1 reference

7 January 2021

Nonnucleoside reverse transcriptase inhibitors that potently and specifically block human immunodeficiency virus type 1 replication

1 reference

7 January 2021

[2',5'-Bis-O-(tert-butyldimethylsilyl)]-3'-spiro-5''-(4''-amino-1'',2''-oxathiole-2'',2''-dioxide) (TSAO) derivatives of purine and pyrimidinenucleosides as potent and selective inhibitors of human immunodeficiency virus type 1

1 reference

7 January 2021

Multiple mutations in HIV-1 reverse transcriptase confer high-level resistance to zidovudine (AZT)

1 reference

7 January 2021

Resistance to ddI and sensitivity to AZT induced by a mutation in HIV-1 reverse transcriptase

1 reference

7 January 2021

Human immunodeficiency virus type 1 mutants resistant to nonnucleoside inhibitors of reverse transcriptase arise in tissue culture

1 reference

7 January 2021

Isolation and characterization of a dideoxyguanosine triphosphate-resistant mutant of human immunodeficiency virus reverse transcriptase

1 reference

7 January 2021

Fifth mutation in human immunodeficiency virus type 1 reverse transcriptase contributes to the development of high-level resistance to zidovudine

1 reference

7 January 2021

In vitro selection of variants of human immunodeficiency virus type 1 resistant to 3'-azido-3'-deoxythymidine and 2',3'-dideoxyinosine

1 reference

7 January 2021

Human immunodeficiency virus type 1 pol gene mutations which cause decreased susceptibility to 2',3'-dideoxycytidine

1 reference

7 January 2021

General aspects of virus drug resistance with special reference to herpes simplex virus

1 reference

7 January 2021

Retroviral Recombination and Reverse Transcription

1 reference

7 January 2021

Susceptibility testing by polymerase chain reaction DNA quantitation: a method to measure drug resistance of human immunodeficiency virus type 1 isolates

1 reference

7 January 2021

Ordered appearance of zidovudine resistance mutations during treatment of 18 human immunodeficiency virus-positive subjects

1 reference

7 January 2021

Persistence of azidothymidine-resistant human immunodeficiency virus type 1 RNA genotypes in posttreatment sera

1 reference

7 January 2021

Incidence of zidovudine-resistant human immunodeficiency virus isolated from patients before, during, and after therapy

1 reference

7 January 2021

Infectious potential of human immunodeficiency virus type 1 reverse transcriptase mutants with altered inhibitor sensitivity

1 reference

7 January 2021

Clinical pharmacology of 3'-azido-2',3'-dideoxythymidine (zidovudine) and related dideoxynucleosides

1 reference

7 January 2021

Rapid and efficient site-specific mutagenesis without phenotypic selection

1 reference

7 January 2021

Complete nucleotide sequences of functional clones of the AIDS virus

1 reference

7 January 2021

DNA sequencing with chain-terminating inhibitors

1 reference

7 January 2021

Cloning of HTLV-4 and its relation to simian and human immunodeficiency viruses

1 reference

7 January 2021

Two-Drug Combinations of Zidovudine, Didanosine, and Recombinant Interferon- A Inhibit Replication of Zidovudine-Resistant Human Immunodeficiency Virus Type 1 Synergistically In Vitro

1 reference

7 January 2021

Identifiers

DOI

10.1038/361650A0

1 reference

26 May 2018

Dimensions Publication ID

1031922245

0 references

1 reference

26 May 2018